Treatment of End Stage Dilated Cardiomyopathy
Br Heart J 72:S52-S56, O'Connell,J.B.,et al, 1996
Neuropsychiatric Aspects of Progressive Supranuclear Palsy
Neurol 47:1184-1189, Litvan,I.,et al, 1996
Cognitive and Brain Magnetic Resonance Imaging Findings in Adrenomyeloneuropathy
Ann Neurol 40:675-678, Edwin,D.,et al, 1996
Cognitive Dysfunction as the Major Presenting Feature of Becker's Muscular Dystrophy
Neurol 46:461-465, North,K.N.,et al, 1996
Clinical Heterogeneity of Adhalin Deficiency
Ann Neurol 39:196-202, Morandi,L.,et al, 1996
MRI of White Matter Changes in the Sjogren-Larsson Syndrome
Neuroradiology 37:576-577, Hussain,M.Z.&Aihara,M., 1996
Clinicopath Conf
Focal Cortical Dysplasia, Case 7-1996, NEJM 334:586-592996., , 1996
Frequency of Dementia in Parkinson Disease
Arch Neurol 42:428-431, Aarsland,D.,et al, 1996
Case-Control Study of Idiopathic Parkinson's Disease and Dietary Vitamin E Intake
Neurol 46:1270-1274, Morens,D.M.,et al, 1996
Clinicopath Conf
Tangier Disease, Case 16-1996, NEJM 334:1389-1394996., , 1996
Intelligence and the X Chromosome
Lancet 347:1814-1815, Turner,G., 1996
The Epilepsy of Trisomy 9p
Neurol 47:821-824, Stern,J.M., 1996
Subcortical Heterotopia:A Distinct Clinicoradiologic Entity
AJNR 17:1315-1322, Barkovich,A.J., 1996
X-Linked Malformation of Neuronal Migration
Neurol 47:331-339, Dobyns,W.B.,et al, 1996
Iron Deficiency Anaemia and Febrile Convulsions:Case-Control Study in Children Under 2 Years
BMJ 313:343, Pisacane,A.,et al, 1996
Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996
Startle Provoked Epileptic Seizures:Features in 19 Patients
JNNP 61:151-156, Manford,M.R.A.,et al, 1996
Adjusted-Dose Warfarin Vs Low-Intens
Fixed-Dose Warfarin+Aspirin for High-Risk Pts with Atrial Fib, SPAFIII Invest, Lancet 348:633-638996, , 1996
An Analysis of Lowest Effective Intensity of Prophylactic Anticoagulation for Pts with Nonrheumatic Atrial Fib
NEJM 335:540-546, 5871996., Hylek,E.M.,et al, 1996
Diagnosis of McArdle's Disease by Molecular Genetic Analysis of Blood
Neurol 47:579-580, El-Schahawi,M.,et al, 1996
Congenital Muscular Dystrophy:Clinical & Pathologic Study of 50 Pts with Classical (Occidental) Merosin-Positive Form
Neurol 46:815-818, Kobayashi,O.,et al, 1996
Congenital Muscular Dystrophy Syndromes Distinguished by Alkaline and Acid Phosphatase, Merosin, & Dystrophin Staining
Neurol 46:810-814, Connolly,A.M.,et al, 1996
The Relation of Transient Hypothyroxinemia in Preterm Infants to Neurologic Development at Two Years of Age
NEJM 334:821-827, 8571996., Reuss,M.L.,et al, 1996
Ethylene Oxide Neurotoxicity:A Cluster of 12 Nurses with Peripheral and Central Nervous System Toxicity
Neurol 46:992-998, Brashear,A.,et al, 1996
Maternal Phenylketonuria:Magnetic Resonance Imaging of the Brain in Offspring
J Pediatr 128:770-775, Levy,H.L.,et al, 1996
Leigh Syndrome:Clinical Features and Biochemical DNA Abnormalities
Ann Neurol 39:343-351, Rahman,S.,et al, 1996
Niemann-Pick Disease Type C from Bench to Bedside
JAMA 276:561-564, Schiffmann,R., 1996
Intellectual Impairment in Children Exposed to Polychlorinated Biphenyls in Utero
NEJM 335:783-789, Jacobson,J.L.,et al, 1996
Risk of Stroke During Long-Term Anticoagulant Therapy in Patients After Myocardial Infarction
Ann Neurol 39:301-307, 2811996., Azar,A.J.,et al, 1996
Clinicopath Conf
Cerebral Amyloid Angiopathy, Case 22-1996, NEJM 335:189-196996., , 1996
The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin
Ann Int Med 124:970-979, Fihn,S.D.,et al, 1996
Dietary Flavonoids, Antioxidant Vitamins, and Incidence of Stroke
Arch Int Med 154:637-642, Keli,S.O.,et al, 1996
Reduced Response to Activated Protein C is Associated with Increased Risk for Cerebrovascular Disease
Ann Int Med 125:265-269, van der Bom,J.G.,et al, 1996
Cerebral Venous Sinus Thrombosis Associated with Factor V Gene Mutation
JNNP 61:204-205, Kimber,T.,et al, 1996
Carotid Artery Thrombus Associated with Severe Iron-Deficiency Anemia and Thrombocytosis
Stroke 27:1002-1005, Akins,P.T.,et al, 1996
Bleeding During Antithrombotic Therapy in Patients with Atrial Fibrillation
Stroke Prevention in Atrial Fib Invest, Arch Int Med 156:409-4161996., , 1996
Differential Effect of Aspirin Vs Warfarin on Clinical Stroke Types in Pts with Atrial Fibrillation
Neurol 46:238-240, Miller,V.T.,et al, 1996
Progressive Ataxia, Focal Seizures, and Malabsorption Syndrome in a 41 Year Old Woman
JNNP 60:225-230, Mumford,C.J.,et al, 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Subjects Not Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:29-361996., , 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Patients Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:37-451996., , 1996
Brief Report:Deficiency of a Dystrophin-Assoc Glycoprotein (Adhalin) in Pt with Muscular Dystrophy & Cardiomyopathy
NEJM 334:362-366, Fadic,R.,et al, 1996
Neurotoxicity Related to the Use of Topical Tretinoin (Retin-A)
Ann Int Med 124:227-228, Bernstein,A.L.&Leventhal-Rochon,J.L., 1996
Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996
Paraneoplastic Limbic Encephalitis in Hodgkin's Disease
Can J Neurol Sci 23:138-140, Deodhare,S.,et al, 1996
In Utero Exposure to Phenobarbital and Intelligence Deficits in Adult Men
JAMA 274:1518-1525, Reinisch,J.M.,et al, 1995
Canavan Disease:From Spongy Degeneration to Molecular Analysis
J Pediatr 127:511-517, Matalon,R.,et al, 1995
Effects of HIV on Cognitive & Motor Devel in Children Born to HIV-Seropositive Women with no Reported Drug Use:Birth-24 mo
Pediatrics 96:1078-1082, Gay,C.L.,et al, 1995
Primary Prevention of Stroke
NEJM 333:1392-1400, Bronner,L.L.,et al, 1995
Cost-Effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients with Nonvalvular Atrial Fibrillation
JAMA 274:1839-1845, Gage,B.F.,et al, 1995
Dopamine, Dystonia, and the Deficient Co-Factor
Lancet 345:1130, Williams,A.C., 1995